News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Innomed Technologies, Inc Release: New Comfort Mask Improves Patient Compliance


10/19/2005 5:10:55 PM

DURHAM, N.C., April 15 /PRNewswire/ -- InnoMed Technologies recently developed a revolutionary facial interface to provide comfort to millions of people suffering from sleep apnea. This mask is critical in providing continuous positive airway pressure (CPAP) therapy for sleep apnea, and the comfort of this mask is a crucial component of the company's efforts to improve patient compliance with sleep-disorder treatments.

"Pharmaceutical Patient Compliance and Disease Management," a report from Cutting Edge Information ( http://www.pharmadiseasemanagement.com/ ), concludes that patients with chronic illnesses, such as sleep problems, diabetes, and hypertension, pose serious threats to their health by not complying with prescribed treatment regimens. In serious cases, estimates conclude that noncompliance causes more than 100,000 deaths per year.

While InnoMed Technologies has improved sleep apnea patient compliance, pharmaceutical companies are also making strides to decrease non-compliance. For example, Roche established a call center for its anti-obesity drug, Xenical. At the call center, trained nurses are available to discuss patients' prescriptions and to answer questions. The call center also conducts reminder calls to consumers at two weeks, one month, three months, and six months.

Cutting Edge Information's report shows how pharmaceutical companies develop customer-focused programs for patients and other consumers. The study contains business practices from top companies including Pfizer, Merck, Aventis, GlaxoSmithKline, Bristol-Myers Squibb, Novartis and Eli Lilly

According to the report, key compliance challenges include the following "big-five" issues:

- The patient fails to fill initial prescription - The patient takes an incorrect dosage - The patient takes medication at the wrong time - The patient forgets to take one or more doses - The patient stops taking the medication too soon

To download the online summary of "Pharmaceutical Patient Compliance and Disease Management" visit http://www.pharmadiseasemanagement.com/ . For more information on this report or to learn about other research being conducted by Cutting Edge Information, contact Diana Borja at Diana_Borja@cuttingedgeinfo.com or 919-433-0219. For media inquiries, call Tricia McGovern at 919-433-0217 or tricia_mcgovern@cuttingedgeinfo.com.

Cutting Edge Information is your one-stop shop for real-company business research. Our reports will help your team execute strategy, understand key business issues, and support your ideas in meetings with key executives. Move ahead of your competition with Information from the Cutting Edge. For more information, call 919-403-6583 or visit http://www.cuttingedgeinfo.com/ .

Cutting Edge Information

CONTACT: Diana Borja, +1-919-433-0219, orDiana_Borja@cuttingedgeinfo.com, or Media, Tricia McGovern, +1-919-433-0217,or tricia_mcgovern@cuttingedgeinfo.com, both of Cutting Edge Information


Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES